SUMMARY A Tufts University investigator and their collaborators at R&D Systems Inc., have developed novel IL-38 analogues to treat neuroinflammatory and neurodegenerative diseases like Autism Spectrum
https://viceprovost.tufts.edu/novel-il-38-analogues-are-potent-inhibitors-neuroinflammatory-mediators